Unknown

Dataset Information

0

Increase of EEG Spectral Theta Power Indicates Higher Risk of the Development of Severe Cognitive Decline in Parkinson's Disease after 3 Years.


ABSTRACT: Objective: We investigated quantitative electroencephalography (qEEG) and clinical parameters as potential risk factors of severe cognitive decline in Parkinson's disease. Methods: We prospectively investigated 37 patients with Parkinson's disease at baseline and follow-up (after 3 years). Patients had no severe cognitive impairment at baseline. We used a summary score of cognitive tests as the outcome at follow-up. At baseline we assessed motor, cognitive, and psychiatric factors; qEEG variables [global relative median power (GRMP) spectra] were obtained by a fully automated processing of high-resolution EEG (256-channels). We used linear regression models with calculation of the explained variance to evaluate the relation of baseline parameters with cognitive deterioration. Results: The following baseline parameters significantly predicted severe cognitive decline: GRMP theta (4-8 Hz), cognitive task performance in executive functions and working memory. Conclusions: Combination of neurocognitive tests and qEEG improves identification of patients with higher risk of cognitive decline in PD.

SUBMITTER: Cozac VV 

PROVIDER: S-EPMC5126063 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Increase of EEG Spectral Theta Power Indicates Higher Risk of the Development of Severe Cognitive Decline in Parkinson's Disease after 3 Years.

Cozac Vitalii V VV   Chaturvedi Menorca M   Hatz Florian F   Meyer Antonia A   Fuhr Peter P   Gschwandtner Ute U  

Frontiers in aging neuroscience 20161129


<b>Objective:</b> We investigated quantitative electroencephalography (qEEG) and clinical parameters as potential risk factors of severe cognitive decline in Parkinson's disease. <b>Methods:</b> We prospectively investigated 37 patients with Parkinson's disease at baseline and follow-up (after 3 years). Patients had no severe cognitive impairment at baseline. We used a summary score of cognitive tests as the outcome at follow-up. At baseline we assessed motor, cognitive, and psychiatric factors;  ...[more]

Similar Datasets

| S-EPMC5786842 | biostudies-literature
| S-EPMC9816433 | biostudies-literature
| S-EPMC4903894 | biostudies-literature
| S-EPMC8058231 | biostudies-literature
| S-EPMC5699050 | biostudies-literature
| S-EPMC5749555 | biostudies-literature
| S-EPMC8291701 | biostudies-literature
| S-EPMC4842380 | biostudies-literature
| S-EPMC7900258 | biostudies-literature
| S-EPMC8329765 | biostudies-literature